{"id":261418,"date":"2026-09-22T11:38:43","date_gmt":"2026-09-22T06:08:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=261418"},"modified":"2026-10-28T11:35:11","modified_gmt":"2026-10-28T06:05:11","slug":"why-bafnaph-share-upper-circuit-consecutive-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/","title":{"rendered":"Bafna Pharmaceuticals Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 28 October 2026"},"content":{"rendered":"<p>Pharma counters often get discussed as a pack, though the Bafna Pharmaceuticals upper circuit streak is a fact about a single stock: <a href=\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\">Bafna Pharmaceuticals Ltd.<\/a> stood at Rs 451.6 on NSE on 28 October 2026, up 2% from the previous close of Rs 442.75, for the second session running at its limit. Nothing in the data lines it up against sector peers, so no such comparison is drawn.<\/p>\n<p>The market cap is Rs 1063.83 crore, and the price was held at the band when this note was written.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Key_Takeaways\" title=\"Key Takeaways\">Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Key_Market_Data\" title=\"Key Market Data\">Key Market Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Price_Action_and_Trading_Activity\" title=\"Price Action and Trading Activity\">Price Action and Trading Activity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#The_Bafna_Pharmaceuticals_Upper_Circuit_Streak_So_Far\" title=\"The Bafna Pharmaceuticals Upper Circuit Streak So Far\">The Bafna Pharmaceuticals Upper Circuit Streak So Far<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Why_Bafna_Pharmaceuticals_Ltd_Hit_Upper_Circuit\" title=\"Why Bafna Pharmaceuticals Ltd. Hit Upper Circuit\">Why Bafna Pharmaceuticals Ltd. Hit Upper Circuit<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#What_the_Bafna_Pharmaceuticals_Upper_Circuit_Means\" title=\"What the Bafna Pharmaceuticals Upper Circuit Means\">What the Bafna Pharmaceuticals Upper Circuit Means<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Bafna_Pharmaceuticals_Ltd_Fundamentals_and_Valuation\" title=\"Bafna Pharmaceuticals Ltd. Fundamentals and Valuation\">Bafna Pharmaceuticals Ltd. Fundamentals and Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Peer_and_Sector_Context\" title=\"Peer and Sector Context\">Peer and Sector Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Technical_Snapshot\" title=\"Technical Snapshot\">Technical Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#What_Readers_Should_Know\" title=\"What Readers Should Know\">What Readers Should Know<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Why_did_Bafna_Pharmaceuticals_Ltd_hit_upper_circuit_on_28_October_2026\" title=\"Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 28 October 2026?\">Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 28 October 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#How_many_sessions_has_Bafna_Pharmaceuticals_Ltd_hit_upper_circuit_in_a_row\" title=\"How many sessions has Bafna Pharmaceuticals Ltd. hit upper circuit in a row?\">How many sessions has Bafna Pharmaceuticals Ltd. hit upper circuit in a row?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#What_was_BAFNAPH_share_price_on_28_October_2026\" title=\"What was BAFNAPH share price on 28 October 2026?\">What was BAFNAPH share price on 28 October 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#What_was_the_upper_circuit_price_for_BAFNAPH\" title=\"What was the upper circuit price for BAFNAPH?\">What was the upper circuit price for BAFNAPH?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#What_is_Bafna_Pharmaceuticals_Ltds_market_cap_and_PE_ratio\" title=\"What is Bafna Pharmaceuticals Ltd.&#8217;s market cap and PE ratio?\">What is Bafna Pharmaceuticals Ltd.&#8217;s market cap and PE ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Which_exchange_and_data_source_were_used\" title=\"Which exchange and data source were used?\">Which exchange and data source were used?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Does_hitting_an_upper_circuit_mean_Bafna_Pharmaceuticals_Ltd_is_a_buy_or_a_sell\" title=\"Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?\">Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#Can_you_buy_or_sell_Bafna_Pharmaceuticals_Ltd_shares_when_the_stock_is_at_the_upper_circuit\" title=\"Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?\">Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#What_happens_the_next_trading_session_after_an_upper_circuit\" title=\"What happens the next trading session after an upper circuit?\">What happens the next trading session after an upper circuit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/why-bafnaph-share-upper-circuit-consecutive-2026\/#What_is_the_upper_circuit_limit_set_at_for_Indian_stocks\" title=\"What is the upper circuit limit set at for Indian stocks?\">What is the upper circuit limit set at for Indian stocks?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span><strong>Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Bafna Pharmaceuticals Ltd. (BAFNAPH) hit the upper circuit on NSE at Rs 451.6 on 28 October 2026.<\/li>\n<li>The session move was +2% against a previous close of Rs 442.75.<\/li>\n<li>Market capitalisation stood at Rs 1063.83 crore with a PE ratio of 136.6.<\/li>\n<li>This is the 2nd straight session at the upper circuit, with the run starting on 27 October 2026.<\/li>\n<li>A price band is an exchange trading rule, not a view on the company or a recommendation.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Key_Market_Data\"><\/span><strong>Key Market Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>Stock<\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\">Bafna Pharmaceuticals Ltd.<\/a><\/td>\n<\/tr>\n<tr>\n<td>Current Price \/ LTP<\/td>\n<td>Rs 451.6<\/td>\n<\/tr>\n<tr>\n<td>Day Move<\/td>\n<td>2%<\/td>\n<\/tr>\n<tr>\n<td>Previous Close<\/td>\n<td>Rs 442.75<\/td>\n<\/tr>\n<tr>\n<td>Day Open<\/td>\n<td>Rs 0<\/td>\n<\/tr>\n<tr>\n<td>Day High<\/td>\n<td>Rs 451.6<\/td>\n<\/tr>\n<tr>\n<td>Day Low<\/td>\n<td>Rs 451.6<\/td>\n<\/tr>\n<tr>\n<td>Upper Circuit Price<\/td>\n<td>Rs 451.6<\/td>\n<\/tr>\n<tr>\n<td>Upper Circuit Limit<\/td>\n<td>Rs 451.6<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 1063.83 crore<\/td>\n<\/tr>\n<tr>\n<td>Selected Exchange<\/td>\n<td>NSE<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>136.6<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All figures above are as of 28 October 2026, sourced from Univest market data for the NSE listing. Only fields present in the source for this session are shown.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Price_Action_and_Trading_Activity\"><\/span><strong>Price Action and Trading Activity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bafna Pharmaceuticals Ltd. traded on NSE with its session high and low both at Rs 451.6, so the day shows no range at all and the price sat on the band price throughout. Set beside the prior close of Rs 442.75, that is a rise of Rs 8.85, which works out to 2%.<\/p>\n<p>The band on this stock is a narrow one, which is why a 2% move already reaches the ceiling. Every number here is an NSE number. A sector peer on another exchange, or one with a wider band, could show a very different percentage at its own limit, so a like-for-like comparison would need data this note does not attempt to supply.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"The_Bafna_Pharmaceuticals_Upper_Circuit_Streak_So_Far\"><\/span><strong>The Bafna Pharmaceuticals Upper Circuit Streak So Far<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This is session 2 of an unbroken run for Bafna Pharmaceuticals Ltd. The streak began on 27 October 2026, from a base price of Rs 440.9. Across the run the stock has moved 2.43% in total.<\/p>\n<p>A repeated upper circuit matters more than a single one. It says the order book has stayed one-sided across multiple sessions rather than reacting to a single day of news, and for anyone holding the stock it means the price on screen has been hard to trade at for several days running.<\/p>\n<p>This page is the running record for the streak and is updated each session rather than being replaced by a fresh article. That keeps one address for the event instead of splitting the same story across competing pages.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Bafna_Pharmaceuticals_Ltd_Hit_Upper_Circuit\"><\/span><strong>Why Bafna Pharmaceuticals Ltd. Hit Upper Circuit<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Buying interest took Bafna Pharmaceuticals Ltd. to the edge of its exchange band, and the upper circuit then held the price at Rs 451.6. Company filings and outside news provided no verified reason for the day, so the pharmaceutical sector is not given credit for the move and price action with sentiment is all that can be read.<\/p>\n<p>Earnings, corporate actions and rumours are also left out as explanations, since none of them is confirmed. If a confirmed announcement comes, a separate update would carry it.<\/p>\n<p>Rs 451.6 was the upper circuit level in the session.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Bafna_Pharmaceuticals_Upper_Circuit_Means\"><\/span><strong>What the Bafna Pharmaceuticals Upper Circuit Means<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>An upper circuit in one pharma stock does not describe the whole group. For Bafna Pharmaceuticals Ltd. the price has reached the ceiling set for the session, Rs 451.6 on 28 October 2026, and the finding applies to this one name only.<\/p>\n<p>Bands exist to slow sharp swings and keep trading orderly. They describe what the sessions did and offer no forecast of returns, and they reveal nothing about how other drug makers traded on the day, so the reading stays with this one stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bafna_Pharmaceuticals_Ltd_Fundamentals_and_Valuation\"><\/span><strong>Bafna Pharmaceuticals Ltd. Fundamentals and Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reported data supplies more context than the price move. Bafna Pharmaceuticals Ltd. carries a market cap of Rs 1063.83 crore, book value of Rs 40.68, EPS of 3.29, a PE ratio of 136.6 and a PB ratio of 11.06. None of it is a buy, sell or hold view.<\/p>\n<p>Against that, book value of Rs 40.68 a share lies far below the quote, and the PB ratio of 11.06 is simply the size of that gap. The PE ratio of 136.6 comes from EPS of 3.29, so the price is a very large multiple of earnings per share. A premium of this size might mirror hopes for growth, the quality of assets or thin trading in a smaller counter, and the ratios on their own do not decide between those. The company is in the healthcare sector, in pharmaceuticals and drugs.<\/p>\n<p>Two sessions at the ceiling attract attention, yet valuation, returns and the sector backdrop each need a review of their own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_and_Sector_Context\"><\/span><strong>Peer and Sector Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bafna Pharmaceuticals Ltd. belongs to the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Peer Company<\/th>\n<th>Market Cap<\/th>\n<th>PE<\/th>\n<th>PB<\/th>\n<th>ROE<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/advenzymes\/advanced-enzyme-technologies-ltd-share-price-today\">Advanced Enzyme Technologies Ltd.<\/a><\/td>\n<td>Rs 2905.78 crore<\/td>\n<td>17.52<\/td>\n<td>1.75<\/td>\n<td>11.43%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\">Hikal Ltd.<\/a><\/td>\n<td>Rs 2494.37 crore<\/td>\n<td>&#8211;<\/td>\n<td>2.09<\/td>\n<td>-3.97%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\">Fredun Pharmaceuticals Ltd.<\/a><\/td>\n<td>Rs 2490.64 crore<\/td>\n<td>56.84<\/td>\n<td>8.17<\/td>\n<td>16.09%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\">Dishman Carbogen Amcis Ltd.<\/a><\/td>\n<td>Rs 2314.9 crore<\/td>\n<td>143.25<\/td>\n<td>0.35<\/td>\n<td>1.56%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\">Beta Drugs Ltd.<\/a><\/td>\n<td>Rs 2151.07 crore<\/td>\n<td>41.43<\/td>\n<td>4.91<\/td>\n<td>18.78%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.<\/p>\n<p>Bafna Pharmaceuticals Ltd.&#8217;s PE ratio was 136.6, compared with an available peer PE average of 64.76, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.<\/p>\n<div class=\"univest-cta\" style=\"border:1px solid #dbe7f3;background:#f8fbff;padding:18px 22px;border-radius:8px;margin:24px 0;\"><strong>Want to know more?<\/strong> <a href=\"https:\/\/univest.in\/user\/log-in\">Log in to Univest<\/a> for more stock insights.<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Snapshot\"><\/span><strong>Technical Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The technical snapshot adds context: RSI was 67.25, the 50-day moving average was 409.26 and the 200-day moving average was 267.75.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Readers_Should_Know\"><\/span><strong>What Readers Should Know<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>What is confirmed is narrow: on 28 October 2026 Bafna Pharmaceuticals Ltd. sat at Rs 451.6, the NSE ceiling, with a 2% gain and a second session at that level. Tying it to the wider drug sector would take evidence that is not part of this note.<\/p>\n<p>At the ceiling, orders queue on the buy side while sellers hold back, so the quoted price is not always one at which a trade completes. No official catalyst has been identified for the move.<\/p>\n<p>Treat this as a market update only. Holding at the ceiling does not stand in for a separate look at the business, its valuation, liquidity, risk and any confirmed company disclosures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Bafna_Pharmaceuticals_Ltd_hit_upper_circuit_on_28_October_2026\"><\/span><strong>Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 28 October 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Bafna_Pharmaceuticals_Ltd_hit_upper_circuit_in_a_row\"><\/span><strong>How many sessions has Bafna Pharmaceuticals Ltd. hit upper circuit in a row?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This is session 2 of the current run, which began on 27 October 2026. This page is updated each session rather than replaced with a new article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_BAFNAPH_share_price_on_28_October_2026\"><\/span><strong>What was BAFNAPH share price on 28 October 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The last traded price used in this article was Rs 451.6 on NSE. That price matched the upper circuit price captured for the event.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_upper_circuit_price_for_BAFNAPH\"><\/span><strong>What was the upper circuit price for BAFNAPH?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The upper circuit price was Rs 451.6. The stated exchange upper circuit limit was Rs 451.6. The event numbers in this article are aligned to NSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Bafna_Pharmaceuticals_Ltds_market_cap_and_PE_ratio\"><\/span><strong>What is Bafna Pharmaceuticals Ltd.&#8217;s market cap and PE ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Bafna Pharmaceuticals Ltd.&#8217;s market cap was Rs 1063.83 crore. PE ratio was 136.6.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_exchange_and_data_source_were_used\"><\/span><strong>Which exchange and data source were used?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_hitting_an_upper_circuit_mean_Bafna_Pharmaceuticals_Ltd_is_a_buy_or_a_sell\"><\/span><strong>Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_you_buy_or_sell_Bafna_Pharmaceuticals_Ltd_shares_when_the_stock_is_at_the_upper_circuit\"><\/span><strong>Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_happens_the_next_trading_session_after_an_upper_circuit\"><\/span><strong>What happens the next trading session after an upper circuit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_upper_circuit_limit_set_at_for_Indian_stocks\"><\/span><strong>What is the upper circuit limit set at for Indian stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Bafna Pharmaceuticals Ltd. the stated limit was Rs 451.6. For this session, Bafna Pharmaceuticals Ltd. moved 2%.<\/p>\n<div style=\"background:#d32f2f;color:#ffffff;padding:16px 20px;border-radius:6px;margin:24px 0;\">\n<p style=\"color:#ffffff;margin:0;\"><strong>Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"headline\":\"Bafna Pharmaceuticals Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 28 October 2026\",\"description\":\"Bafna Pharmaceuticals upper circuit streak on NSE on 28 October 2026: the stock was locked at Rs 451.6, a 2% move. Price action, valuation and peer context.\",\"datePublished\":\"2026-10-28T06:04:57.335Z\",\"dateModified\":\"2026-10-28T06:04:57.335Z\",\"inLanguage\":\"en-IN\",\"articleSection\":\"Stock Market News\",\"keywords\":\"Bafna Pharmaceuticals upper circuit streak, Bafna Pharmaceuticals Ltd. share price, BAFNAPH upper circuit, upper circuit stocks today\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Bafna Pharmaceuticals Ltd.\",\"tickerSymbol\":\"BAFNAPH\",\"industry\":\"Pharmaceuticals & Drugs\",\"url\":\"https:\/\/univest.in\/stocks\/bafnaph\/bafna-pharmaceuticals-ltd-share-price-today\"},\"mentions\":[{\"@type\":\"Corporation\",\"name\":\"Advanced Enzyme Technologies Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Hikal Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Fredun Pharmaceuticals Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Dishman Carbogen Amcis Ltd.\"},{\"@type\":\"Corporation\",\"name\":\"Beta Drugs Ltd.\"}],\"citation\":[]},{\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why did Bafna Pharmaceuticals Ltd. hit upper circuit on 28 October 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.\"}},{\"@type\":\"Question\",\"name\":\"How many sessions has Bafna Pharmaceuticals Ltd. hit upper circuit in a row?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This is session 2 of the current run, which began on 27 October 2026. This page is updated each session rather than replaced with a new article.\"}},{\"@type\":\"Question\",\"name\":\"What was BAFNAPH share price on 28 October 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The last traded price used in this article was Rs 451.6 on NSE. That price matched the upper circuit price captured for the event.\"}},{\"@type\":\"Question\",\"name\":\"What was the upper circuit price for BAFNAPH?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The upper circuit price was Rs 451.6. The stated exchange upper circuit limit was Rs 451.6. The event numbers in this article are aligned to NSE.\"}},{\"@type\":\"Question\",\"name\":\"What is Bafna Pharmaceuticals Ltd.'s market cap and PE ratio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Bafna Pharmaceuticals Ltd.'s market cap was Rs 1063.83 crore. PE ratio was 136.6.\"}},{\"@type\":\"Question\",\"name\":\"Which exchange and data source were used?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.\"}},{\"@type\":\"Question\",\"name\":\"Does hitting an upper circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.\"}},{\"@type\":\"Question\",\"name\":\"Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the upper circuit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.\"}},{\"@type\":\"Question\",\"name\":\"What happens the next trading session after an upper circuit?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.\"}},{\"@type\":\"Question\",\"name\":\"What is the upper circuit limit set at for Indian stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Bafna Pharmaceuticals Ltd. the stated limit was Rs 451.6. For this session, Bafna Pharmaceuticals Ltd. moved 2%.\"}}]}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Bafna Pharmaceuticals upper circuit streak on NSE on 28 October 2026: the stock was locked at Rs 451.6, a 2% move. Price action, valuation and peer context.<\/p>\n","protected":false},"author":35,"featured_media":330049,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-261418","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["330049"],"rank_math_title":["Bafna Pharmaceuticals Upper Circuit Streak: Day 2 Price and Data"],"rank_math_description":["Bafna Pharmaceuticals upper circuit streak on NSE on 28 October 2026: the stock was locked at Rs 451.6, a 2% move. Price action, valuation and peer context."],"rank_math_focus_keyword":["Bafna Pharmaceuticals upper circuit streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/bafna-pharmaceuticals-ltd-hits-upper-circuit-for-the-2nd-straight-session-on-nse.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=261418"}],"version-history":[{"count":12,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261418\/revisions"}],"predecessor-version":[{"id":330050,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261418\/revisions\/330050"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/330049"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=261418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=261418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=261418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}